225
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Predictive value of increased nuchal translucency as a screening test for the detection of fetal chromosomal abnormalities

, , , , , , , , , , , , & show all
Pages 857-862 | Received 30 Oct 2008, Accepted 13 Mar 2009, Published online: 15 Sep 2009

References

  • Snijders R JM, Noble P, Sebire N, Souka A, Nicolaides K H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10–14 week of gestation. Lancet 1998; 351: 343–346
  • Nicolaides K H, Sebire J, Neil, Snijders R JM. The 11–14 week scan – chapter 1.3, Available: www.fetalmedicine.com via the INTERNET. Accessed 2007
  • Nicolaides K H. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191: 45–46
  • Chasen S T, Sharma G, Kalish R B, Chervenak F A. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population. Ultrasound Obstet Gynecol 2003; 22: 149–151
  • Comas C, Torrents M, Munoz A, Antolin E, Figueras F, Echevarria M. Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker?. Obstet Gynecol 2002; 100: 648–654
  • Von Kaisenberg C S, Gasiorek-Wiens A, Bielicki M, Bahlmann F, Meyberg H, Kossakiewicz A, Pruggmayer M, Kamin G, Fritzer E, Harris C, et al. German Speaking Down Syndrome Screening Group. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11–14 weeks: a German multicenter study. J Matern Fetal Neonatal Med 2002; 12: 89–94
  • Prefumo F, Thilaganathan B. Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening. Prenat Diagn 2002; 22: 917–918
  • Panburana P, Ajjimakorn S, Tungkajiwangoon P. First trimester Down Syndrome screening by nuchal translucency in a Thai population. Int J Gynaecol Obstet 2001; 75: 311–312
  • Zoppi M A, Ibba R M, Floris M, Monni G. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia. Ultrasound Obstet Gynecol 2001; 18: 649–651
  • Michailides G D, Economides D L. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001; 17: 102–105
  • Souka A P, von Kaisenberg C S, Hyett J A, Sonek J D, Nicolaides K H. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005; 92: 1005–1021
  • Souka A P, Krampl E, Bakalis S, Heath V, Nicolaides K H. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001; 18: 9–17
  • Pandya P P, Snijders R JM, Johnson S J, Brizot M, Nicolaides K H. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynecol 1995; 102: 957–962
  • Nicolaides K H. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191: 45–67
  • Thilaganathan B, Sairam S, Michailidis G, Wathen N C. First trimester nuchal translucency: effective routine screening for Down's syndrome. Br J Radiol 1999; 72: 946–948
  • Theodoropoulos P, Lolis D, Papageorgiou C, Papaioannou S, Plachouras N, Makrydimas G. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age. Prenat Diagn 1998; 18: 133–137
  • Pandya P P, Kondylios A, Hilbert L, Snijders R JM, Nicolaides K H. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995; 5: 15–19
  • Brambati B, Cislaghi C, Tuli L, Alberti E, Amidani M, Colombo U, Zuliani G. First trimester Down's syndrome screening using nuchal translucency: a prospective study. Ultrasound Obstet Gynecol 1995; 5: 9–14
  • Comas C, Martinez J M, Ojuel J, Casal E, Puerto B, Borrell A, Fortuny A. First-trimester nuchal edema as a marker of aneuploidy. Ultrasound Obstet Gynecol 1995; 5: 26–29
  • Pajkrt E, Mol B W, van Lith J M, Bleker O P, Bilardo C M. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population. Ultrasound Obstet Gynecol 1998; 12: 156–162
  • Taipale P, Hiilesmaa V, Salonen R, Ylostalo P. Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med 1997; 337: 1654–1658
  • Snijders R J, Sebire N J, Nayar R, Souka A, Nicolaides K H. Increased nuchal translucency in trisomy 13 fetuses at 10–14 weeks of gestation. Am J Med Genet 1999; 86: 205–207
  • Sebire N J, Snijders R JM, Davenport M, Greenough A, Nicolaides K H. Fetal nuchal translucency thickness at 10–14 weeks of gestation and congenital diaphragmatic hernia. Obstet Gynecol 1997; 90: 943–947
  • Ville Y, Lalondrelle C, Doumerc S, Daffos F, Frydman R, Oury J F, Dumez Y. First-trimester diagnosis of nuchal anomalies: significance and fetal outcome. Ultrasound Obstet Gynecol 1992; 2: 314–316
  • Szabo J, Gellen J, Szemere G. First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age. Ultrasound Obstet Gynecol 1995; 5: 3161–3163
  • Savoldelli G, Binkert F, Achermann J, Schmid W. Ultrasound screening for chromosomal anomalies in the first trimester of pregnancy. Prenat Diagn 1993; 13: 513–518
  • Van Zalen-Sprock M M, Van Vugt J MG, Van Geijn H P. First- trimester diagnosis of cystic hygroma- course and outcome. Am J Obstet Gynecol 1992; 167: 94–98
  • Suchet I B, Van der Westhuizen N G, Labatte M F. Fetal cystic hygromas: further insights into their natural history. Can Assoc Radiol J 1992; 6: 420–424
  • Nicolaides K H, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992; 304: 867–869
  • Nicolaides K H, Brizot M L, Patel F, Snijders R JM. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10 – 13 weeks gestation. Lancet 1994; 344: 435–439

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.